PACS Group (PACS) has moved into focus after reporting strong first quarter 2026 results, raising full year earnings guidance, and unveiling a new US$250 million share repurchase program alongside ongoing acquisition plans.

The recent earnings beat, higher adjusted EBITDA guidance and new US$250 million buyback have come after a sharp 1 year total shareholder return of about 2.5x, even as the share price return year to date is down 5.1% with near term momentum still choppy following a 5.5% drop on the latest day.

If PACS Group’s mix of acquisitions and buybacks has your attention, this can be a good moment to broaden your search and check out 32 healthcare AI stocks

So, with PACS now trading about 30% below the average analyst price target and at roughly a 39% discount to some intrinsic value estimates after a 2.5x 1 year total return, are you looking at a fresh opportunity or a stock already pricing in future growth?

Most Popular Narrative: 7.1% Overvalued

The most followed narrative puts PACS Group’s fair value at $35, slightly below the last close of $37.48, which frames the latest pullback in a different light.

A robust pipeline of internally developed administrators and leaders through the AIT program supports scalable execution as the industry consolidates, enabling disciplined M&A at attractive valuations that is accretive to adjusted EBITDA and long-term earnings growth.

Want to see the full playbook behind that fair value? The narrative leans heavily on more facilities, richer margins, and a very specific profit profile in a few years.

Result: Fair Value of $35 (OVERVALUED)

However, there is still real execution risk if newer facilities take longer to ramp or if reimbursement frameworks in key states shift against current assumptions.

Another Take: DCF Says Undervalued

That 7.1% “overvalued” call based on a $35 fair value is only half the story. Simply Wall St’s DCF model puts PACS Group’s value closer to $60.98 per share, about 39% above the current $37.48 price. This raises a simple question: which set of assumptions do you trust more?

Next Steps

With sentiment clearly split, do not wait for others to decide for you. Review the full picture of risks and rewards and check out 4 key rewards and 2 important warning signs

Looking for more investment ideas?

If PACS Group has sharpened your focus, do not stop here. Broaden your watchlist now or you risk missing opportunities that better fit your style.

• Target resilient balance sheets by scanning companies in the solid balance sheet and fundamentals stocks screener (45 results) built for investors who care about financial strength first.
• Spot potential value candidates early by searching through the screener containing 22 high quality undiscovered gems before they appear on everyone else's radar.
• Prioritise stability in rough markets by checking stocks in the 66 resilient stocks with low risk scores that aim to keep overall portfolio risk in check.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.